Ignite Creation Date:
2025-12-24 @ 6:40 PM
Ignite Modification Date:
2026-05-04 @ 12:32 AM
Study NCT ID:
NCT00973557
Status:
COMPLETED
Last Update Posted:
2012-02-07
First Post:
2009-09-08
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
The Effect of Monoclonal Vascular Endothelial Growth Factor (VEGF) Antibody (Bevacizumab) on Pituitary Function
Sponsor:
Cedars-Sinai Medical Center
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
Pro00019830
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None